Projects per year
Personal profile
Education
- 1993 PhD,Department of Genetics, Michigan State University
Experience
- 1995~1999 Associate Professor, Institute of Toxicology, Chung Shan Medical Univ., Taichung, Taiwan
- 1999~2006 Professor, Department of Life Science, National Taiwan Normal Univ., Taipei, Taiwan
- 2006~2015 Distinguished Professor, Department of Pharmacology, National Cheng Kung University, Tainan, Taiwan
- 2015~now Chair Professor, Department of Pharmacology & Institute of Basic Medical Science & Institute of Clinical Medical Science, National Cheng Kung University, Tainan, Taiwan
Research Interests
- Molecular cancer biology
- Cancer epigenetics
- Transcription deregulation in cancer
- Vesicle trafficking in tumor microenvironment
- Anticancer drug development
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Yi-Ching Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 40 Finished
-
-
食道癌化放療抗性之轉錄體機制研究及臨床應用分析-NRF2轉錄成癮導致食道癌化放療抗性之機轉研究及臨床驗證( II )
21-08-01 → 22-07-31
Project: Research project
-
-
-
食道癌化放療抗性之轉錄體機制研究及臨床應用分析-NRF2轉錄成癮導致食道癌化放療抗性之機轉研究及臨床驗證( I )
20-08-01 → 21-07-31
Project: Research project
-
Nutlin-3 acts as a DNA methyltransferase inhibitor to sensitize esophageal cancer to chemoradiation
Chang, W. L., Hsieh, C. H., Kuo, I. Y., Lin, C. H., Huang, Y. L. & Wang, Y. C., 2023 Feb, In: Molecular Carcinogenesis. 62, 2, p. 277-287 11 p.Research output: Contribution to journal › Article › peer-review
-
Carboxypeptidase E mRNA: Overexpression predicts recurrence and death in lung adenocarcinoma cancer patients
Kuo, I. Y., Liu, D., Lai, W. W., Wang, Y. C. & Loh, Y. P., 2022, In: Cancer Biomarkers. 33, 3, p. 369-377 9 p.Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus) -
Cerium-based metal–organic framework as an electrocatalyst for the reductive detection of dopamine
Chiang, Y. T., Gu, Y. J., Song, Y. D., Wang, Y. C. & Kung, C. W., 2022 Feb, In: Electrochemistry Communications. 135, 107206.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Correction to: YAP1 acts as a negative regulator of pro-tumor TAZ expression in esophageal squamous cell carcinoma (Cellular Oncology, (2022), 45, 5, (893-909), 10.1007/s13402-022-00695-4)
Kuo, Y. Z., Kang, Y. R., Chang, W. L., Sim, L. C. L., Hsieh, T. C., Chang, C. H., Wang, Y. C., Tsai, C. J., Huang, L. C., Tsai, S. T. & Wu, L. W., 2022 Oct, In: Cellular Oncology. 45, 5, p. 911 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma
Hsieh, C. H., Kuan, W. H., Chang, W-L., Kuo, I-Y., Liu, H., Shieh, D. B., Liu, H., Tan, B. & Wang, Y-C., 2022 Dec, In: Journal of biomedical science. 29, 1, 90.Research output: Contribution to journal › Article › peer-review
Open Access